Informations générales (source: ClinicalTrials.gov)
Early Palliative Care for Patients With Haematological Malignancies: A Randomised Prospective Study (CALVI)
Interventional
Phase 3
University Hospital, Clermont-Ferrand (Voir sur ClinicalTrials)
mars 2019
décembre 2023
29 juin 2024
Patients suffering from haematological disease present symptoms of discomfort and
currently benefit from palliative care skills only for the management of their
end-of-life. However, in medical oncology, more and more studies tend to demonstrate the
benefit on the quality of life of an early collaboration between the two specialties.
Investigator did the hypothesis that early integration of palliative care with
conventional haematological care could decrease discomfort symptoms and add a real
benefit on the patients' quality of life .
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Centre Hospitalier Métropole Savoie - 73000 - Chambéry - France | Laurent SUTTON | Contact (sur clinicalTrials) | |||
| Chu Clermont-Ferrand - 63003 - Clermont-Ferrand - France | Lise LACLAUTRE | Contact (sur clinicalTrials) | |||
| Chu Limoges - 87042 - Limoges - France | Stéphane MOREAU | Contact (sur clinicalTrials) | |||
| Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
| Centre Léon Bérard - 69008 - Lyon - France | Anne-Sophie MICHALLET | Contact (sur clinicalTrials) | |||
| CH Jacques Lacarin - 03200 - Vichy - France | Karine SOULIER-GUERIN | Contact (sur clinicalTrials) | |||
| Institut de Cancérologie de la Loire - 42271 - Saint-Priest-en-Jarez - France | Denis GUYOTAT | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Patients are over 70 years old
- Patients from being diagnosed with acute myeloid leukemia and high-risk
myelodysplastic syndrome or after the third line of therapy for high-grade lymphoma.
- Patients are over 70 years old
- Patients from being diagnosed with acute myeloid leukemia and high-risk
myelodysplastic syndrome or after the third line of therapy for high-grade lymphoma.
- All patients with a curative project (induction chemotherapy ou allogenic
transplantation)
- All patients in a terminal palliative status
- Patients who don't speak French,
- Patients not able to read and write
- Patients who don't agree to participate in the protocol
- Patients with psychiatric troubles or cognitive disorders
- Patients under guardianship or curatorship, deprived of freedom or under justice
protection.